Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-02

Clinical Trial Update: Silodosin vs Placebo in the Treatment of Female LUTS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating silodosin versus placebo for female lower urinary tract symptoms (LUTS). Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

Sponsor: Mansoura University | Conditions: Lower Urinary Tract Symptoms | Phase 3 | Status: UNKNOWN